This study was designed to determine the effect of preventative therapy with ABC294640, a competitive SK2 inhibitor, on the lupus phenotype in a murine model of lupus and to explore potential mechanisms through which this therapy might be acting to improve outcomes. Here, SPHK2 is linked to systemic lupus erythematosus.